34
Participants
Start Date
June 30, 2010
Primary Completion Date
May 31, 2012
Study Completion Date
May 31, 2012
Add Vildagliptin
Adding Vildagliptin 50 mg bid to patients with type 2 diabetes mellitus being treated with metformin 500-1000mg bid per day who had hemoglobin A1c of 7.0-10.0%
Add Glimepiride
Adding Glimepiride 2mg to patients with type 2 diabetes mellitus being treated with metformin 500-1000mg bid per day who had hemoglobin A1c of 7.0-10.0%
Division of Endocrinology and Metabolism, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul
Collaborators (1)
Novartis
INDUSTRY
Samsung Medical Center
OTHER